Best practices in liver biopsy histologic assessment for nonalcoholic steatohepatitis clinical trials: expert opinion

CM Filozof, C Lackner, M Romero-Gómez… - …, 2022 - Wiley Online Library
Background. In most clinical trials focusing on precirrhotic nonalcoholic steatohepatitis
(NASH), a liver biopsy is required for confirmation of diagnosis, staging fibrosis, and grading …

[HTML][HTML] Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH

J Conway, M Pouryahya, Y Gindin, DZ Pan… - Cell Reports …, 2023 - cell.com
Nonalcoholic steatohepatitis (NASH) is the most common chronic liver disease globally and
a leading cause for liver transplantation in the US. Its pathogenesis remains imprecisely …

[ЦИТАТА][C] View All

AIP Menu, JOP Network